How is cirrhosis diagnosed?

August 18, 2024

 The Non Alcoholic Fatty Liver Strategy™ eBook by Julissa Clay. The program provided in this eBook is very reasonable and realistic as it neither restricts your diet miserably so that you cannot stick to the changes in diet suggested in it nor wants you to do intense exercises for many hours every week. This program helps in making big changes in your life by following a few easy-to-follow steps.


How is cirrhosis diagnosed?

Cirrhosis is diagnosed through a combination of clinical evaluation, blood tests, imaging studies, and sometimes a liver biopsy. It is the advanced stage of liver fibrosis, characterized by severe scarring of the liver that impairs its function. Early detection is crucial for managing cirrhosis and preventing further complications. Here’s how cirrhosis is typically diagnosed:

1. Clinical Evaluation

  • Medical History: Doctors assess the patient’s medical history, including risk factors for liver disease such as chronic alcohol use, viral hepatitis, non-alcoholic fatty liver disease (NAFLD), or other liver conditions.
  • Physical Examination: A physical exam may reveal signs of advanced liver disease, such as:
    • Jaundice: Yellowing of the skin and eyes due to impaired bilirubin metabolism.
    • Spider Angiomas: Small, spider-like blood vessels on the skin.
    • Palmar Erythema: Redness of the palms.
    • Ascites: Accumulation of fluid in the abdomen, often causing abdominal swelling.
    • Hepatomegaly: Enlarged liver.
    • Splenomegaly: Enlarged spleen.
    • Gynecomastia: Enlargement of breast tissue in men due to hormonal imbalances.

2. Blood Tests

  • Liver Function Tests (LFTs): These measure enzymes and proteins produced by the liver to assess liver function and damage.
    • Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST): Elevated levels may indicate liver damage. In cirrhosis, these levels may normalize as liver cells become less functional.
    • Alkaline Phosphatase (ALP) and Gamma-Glutamyl Transferase (GGT): Often elevated in bile duct disorders and liver damage.
    • Bilirubin: High levels indicate impaired liver function, as the liver is unable to process and excrete bilirubin effectively.
    • Albumin and Total Protein: Low levels suggest poor liver function, as the liver is responsible for producing these proteins.
    • Prothrombin Time (PT) and International Normalized Ratio (INR): Prolonged clotting times indicate impaired production of clotting factors, which are synthesized by the liver.
  • Complete Blood Count (CBC): This can detect signs of liver disease, such as low platelet counts (thrombocytopenia), which often occur due to splenomegaly in cirrhosis.
  • Tests for Liver Fibrosis: Blood tests such as the Fibrosis-4 (FIB-4) index or Enhanced Liver Fibrosis (ELF) score may be used to assess the degree of liver fibrosis and the likelihood of cirrhosis.

3. Imaging Studies

  • Ultrasound: An abdominal ultrasound is commonly used to assess the liver’s size, texture, and structure. It can reveal:
    • Liver Nodularity: The surface of the liver may appear irregular due to scarring.
    • Ascites: Fluid in the abdominal cavity.
    • Splenomegaly: Enlarged spleen.
    • Portal Hypertension: Increased pressure in the portal vein can sometimes be inferred from ultrasound findings, such as dilated blood vessels.
  • Transient Elastography (FibroScan): This non-invasive imaging test measures liver stiffness, which correlates with the extent of fibrosis and cirrhosis. It provides a quantitative assessment of liver scarring.
  • Magnetic Resonance Elastography (MRE): This advanced imaging technique uses MRI to measure liver stiffness. It provides a more detailed assessment than FibroScan but is less widely available.
  • CT Scan or MRI: These imaging techniques can provide more detailed images of the liver, identifying structural changes, cirrhotic nodules, and complications like hepatocellular carcinoma (liver cancer).

4. Liver Biopsy

  • Gold Standard for Diagnosis: A liver biopsy is sometimes performed to definitively diagnose cirrhosis and determine its severity. This involves taking a small tissue sample from the liver, which is examined under a microscope to assess the degree of scarring and liver cell damage.
  • Procedure: Liver biopsy is an invasive procedure with some risks, such as bleeding or infection. Therefore, it is generally reserved for cases where non-invasive tests are inconclusive, or more precise staging of cirrhosis is required.

5. Additional Diagnostic Tests

  • Endoscopy: Upper endoscopy may be performed to check for complications of cirrhosis, such as esophageal varices (enlarged veins in the esophagus) caused by portal hypertension. This procedure allows doctors to visualize and treat varices before they bleed, which is a serious complication of cirrhosis.
  • Liver Function Tests for Child-Pugh and MELD Scores: These scoring systems help assess the severity of cirrhosis and guide treatment decisions.
    • Child-Pugh Score: Evaluates liver function based on bilirubin, albumin, INR, ascites, and hepatic encephalopathy (brain dysfunction due to liver disease). It classifies cirrhosis into classes A, B, or C (mild, moderate, or severe).
    • MELD Score (Model for End-Stage Liver Disease): A mathematical score that predicts the risk of mortality in patients with cirrhosis, often used to prioritize liver transplant candidates.

6. Signs and Symptoms of Complications

  • Hepatic Encephalopathy: Confusion, disorientation, and memory issues caused by the buildup of toxins in the brain due to liver dysfunction.
  • Portal Hypertension: High pressure in the portal vein leading to esophageal varices, ascites, and splenomegaly.
  • Hepatorenal Syndrome: Kidney dysfunction resulting from advanced liver disease.
  • Liver Cancer (Hepatocellular Carcinoma): Cirrhosis is a significant risk factor for liver cancer, and regular screening for hepatocellular carcinoma (HCC) is recommended for patients with cirrhosis.

Conclusion

Cirrhosis is diagnosed through a combination of clinical evaluation, blood tests, imaging studies (such as ultrasound, FibroScan, or MRI), and, in some cases, liver biopsy. Doctors may also use endoscopy to detect complications like esophageal varices. Early diagnosis and regular monitoring are crucial for managing cirrhosis, preventing complications, and determining the need for interventions such as liver transplantation.

 The Non Alcoholic Fatty Liver Strategy™ eBook by Julissa Clay. The program provided in this eBook is very reasonable and realistic as it neither restricts your diet miserably so that you cannot stick to the changes in diet suggested in it nor wants you to do intense exercises for many hours every week. This program helps in making big changes in your life by following a few easy-to-follow steps.